Coronary Artery Disease Clinical Trials in Houston, Texas

6 studies are recruiting for coronary artery disease in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Houston, Texas

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

   Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

   Stage

   Not phased

   Ages

   Any age

   Site

   Houston Methodist Hospital, Houston, Texas

   Locations

   48 in total

   Run by

   Minneapolis Heart Institute Foundation

   See if you can join NCT02061436 on ClinicalTrials.gov

3. Prevail Global Study

   The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

   Stage

   Not phased

   Ages

   18 and older

   Site

   HCA Houston Medical Center, Houston, Texas

   Locations

   51 in total

   Run by

   Medtronic Vascular

   See if you can join NCT06535854 on ClinicalTrials.gov

4. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

   Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas

   Locations

   9 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05618353 on ClinicalTrials.gov

5. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor College of Medicine, Houston, Texas

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov

6. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   HCA Houston Healthcare Medical Center, Houston, Texas

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov